Background illustration for clinical trials search

Paid Clinical Trials Omaha

Discover 602 paid clinical trials in Omaha, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for
Diabetes Mellitus, Type 2, Hypertension,
Location: Omaha NE, Fremont NE, Dakota Dunes SD, Topeka KS,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07064473

Phase3, Recruiting
Active & Responsive

A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma

for
Clear Cell Renal Cell Carcinoma
Location: Omaha NE
Sponsor: PeptiDream Inc.

Sex: All

Age: 18+

Code: NCT07688187

Phase1, Recruiting
Active & Responsive

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

for
Metastatic Castration-resistant Prostate Cancer
Location: Omaha NE, Houston TX, Metairie LA, Dothan AL, Montreal,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT07611110

Phase3, Recruiting
Active & Responsive

Early Detection of COPD Exacerbations Using Home Monitoring Device

for
COPD Exacerbation
Location: Omaha NE
Sponsor: RespirAI US Inc

Sex: All

Age: 21+

Code: NCT07554352

Recruiting
Active & Responsive

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

for
Percutaneous Coronary Intervention,
Location: Omaha NE, Lincoln NE, West Des Moines IA,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06909565

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

for
Overactive Bladder (OAB)
Location: Omaha NE, Sioux Falls SD, Barrington IL, Charlotte NC,
Sponsor: FemPulse Corporation

Sex: Female

Age: 21+

Code: NCT07195656

Recruiting
Active & Responsive

A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).

for
Healthy
Location: Omaha NE, Lincoln NE, Kansas City MO, Springfield MO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 12 - 30

Code: NCT06655324

Phase1, Recruiting
Active & Responsive

A Study of V132 in Healthy Older Participants (V132-001)

for
Healthy
Location: Omaha NE, Lincoln NE, Springfield MO, Columbus OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 50 - 70+

Code: NCT07712575

Phase1, Recruiting
Active & Responsive

Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

for
Graves' Disease
Location: Omaha NE, Amarillo TX, Dallas TX, Bowling Green KY,
Sponsor: Yarrow Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT07682896

Phase2, Recruiting
Active & Responsive

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

for
Age-Related Macular Degeneration, Geographic Atrophy
Location: Omaha NE, Birmingham MI, Cleveland OH, Houston TX,
Sponsor: VisionCare, Inc.

Sex: All

Age: 65+

Code: NCT05438732

Recruiting
Active & Responsive

A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production

for
Developmental Language Disorder, Speech Sound Disorder,
Location: Omaha NE, Tucson AZ
Sponsor: Father Flanagan's Boys' Home

Sex: All

Age: 4 - 8

Code: NCT04558541

Recruiting
Active & Responsive

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

for
Non-segmental Vitiligo
Location: Omaha NE, Indianapolis IN, Plano TX, Winnipeg,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07431177

Phase2, Recruiting
Active & Responsive

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Omaha NE, Tulsa OK, Oklahoma City OK, Chickasha OK,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05995964

Phase2, Recruiting
Active & Responsive

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

for
Menstrual Migraine
Location: Papillion NE, Springfield MO, Weldon Spring MO,
Sponsor: Pfizer

Sex: Female

Age: 18 - 45

Code: NCT06641466

Phase3, Recruiting
Active & Responsive

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: Omaha NE, Rochester MN, Zion IL, Irving TX,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07277413

Phase1, Recruiting
Active & Responsive

A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Location: Omaha NE, West Hollywood CA
Sponsor: Oncotherapeutics

Sex: All

Age: 0+

Code: NCT06115135

Phase2, Recruiting
Active & Responsive

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

for
Solid Tumors
Location: Omaha NE, Wichita KS, Rochester MN, Saint Paul MN,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07415031

Phase2, Recruiting
Active & Responsive

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

for
Castration-Resistant Prostate Cancer (CRPC), Colorectal Cancer,
Location: Omaha NE, Grand Rapids MI, Houston TX, Dothan AL
Sponsor: Radiopharm Theranostics, Ltd

Sex: All

Age: 18+

Code: NCT07189871

Phase1, Phase2, Recruiting
Active & Responsive

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: Omaha NE, St Louis MO, Grand Rapids MI, Dallas TX,
Sponsor: Tasca Therapeutics

Sex: All

Age: 18+

Code: NCT07030257

Phase1, Phase2, Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Omaha NE, Sioux Falls SD, Westwood KS, Wichita KS,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting